U. Raza Et Al. , "The miR-644a/CTBP1/p53 axis suppresses drug resistance by simultaneous inhibition of cell survival and epithelial-mesenchymal transition in breast cancer," ONCOTARGET , vol.7, no.31, pp.49859-49877, 2016
Raza, U. Et Al. 2016. The miR-644a/CTBP1/p53 axis suppresses drug resistance by simultaneous inhibition of cell survival and epithelial-mesenchymal transition in breast cancer. ONCOTARGET , vol.7, no.31 , 49859-49877.
Raza, U., Saatci, O., Uhlmann, S., Ansari, S. A., Eyupoglu, E., Yurdusev, E., ... Mutlu, M.(2016). The miR-644a/CTBP1/p53 axis suppresses drug resistance by simultaneous inhibition of cell survival and epithelial-mesenchymal transition in breast cancer. ONCOTARGET , vol.7, no.31, 49859-49877.
Raza, Umar Et Al. "The miR-644a/CTBP1/p53 axis suppresses drug resistance by simultaneous inhibition of cell survival and epithelial-mesenchymal transition in breast cancer," ONCOTARGET , vol.7, no.31, 49859-49877, 2016
Raza, Umar Et Al. "The miR-644a/CTBP1/p53 axis suppresses drug resistance by simultaneous inhibition of cell survival and epithelial-mesenchymal transition in breast cancer." ONCOTARGET , vol.7, no.31, pp.49859-49877, 2016
Raza, U. Et Al. (2016) . "The miR-644a/CTBP1/p53 axis suppresses drug resistance by simultaneous inhibition of cell survival and epithelial-mesenchymal transition in breast cancer." ONCOTARGET , vol.7, no.31, pp.49859-49877.
@article{article, author={Umar Raza Et Al. }, title={The miR-644a/CTBP1/p53 axis suppresses drug resistance by simultaneous inhibition of cell survival and epithelial-mesenchymal transition in breast cancer}, journal={ONCOTARGET}, year=2016, pages={49859-49877} }